IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Stryker Corporation and Encourages Investors with Losses to Contact the Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Stryker Corporation ("Stryker" or the "Company") SYK concerning possible violations of federal securities laws.

If you purchased shares of Stryker and want more information, please contact Joon M. Khang, Esquire, of Khang & Khang LLP, 4000 Barranca Parkway, Suite 250 Irvine, CA 92604, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

The investigation concerns whether Stryker and certain of its officers and/or directors violated federal securities laws. On August 23, 2017, the Company announced that it informed the Food and Drug Administration ("FDA") of a voluntary product recall involving specific lots of its Oral Care products distributed between July 2015 and August 2017. Stryker's recall followed a warning letter from the FDA received on July 17, 2017, which described a potential for cross-contamination of Oral Care products manufactured by a third party on equipment shared with non-pharmaceutical products. After receiving reports of minor irritation and allergic reaction, the Company discontinued its business relationship with the third-party supplier. Based on the estimated impact of the foregoing issues on sales and operating income, Stryker advised investors that the Company now expects full-year organic sales growth and adjusted net earnings per diluted share to be at the lower end of its previously stated ranges of 6.5% to 7.0% and $6.45 to $6.55, respectively. When this news was announced, shares of Stryker fell in value.

If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170825005560/en/